Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017
Wed, September 13, 2017
Tue, September 12, 2017
Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017
Tue, September 5, 2017
Fri, September 1, 2017
Thu, August 31, 2017
Wed, August 30, 2017
Tue, August 29, 2017
Mon, August 28, 2017
Fri, August 25, 2017
Thu, August 24, 2017
Wed, August 23, 2017
Tue, August 22, 2017
Mon, August 21, 2017
Fri, August 18, 2017
Thu, August 17, 2017

Geoff Meacham Initiated (ALNY) at Buy with Increased Target to $105 on, Sep 7th, 2017


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-105-on-sep-7th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Geoff Meacham of Barclays, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $80 to $105 on, Sep 7th, 2017.

Geoff has made no other calls on ALNY in the last 4 months.



There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, all agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $50 on, Thursday, August 10th, 2017

Publication Contributing Sources